Impact of Type 1 Diabetes and Its Duration on Wall-to-lumen Ratio and Blood Flow in Retinal Arterioles
Abstract Background Subclinical damage to both the small and large vessels may contribute to the development and progression of cardiovascular disease. Scanning laser Doppler flowmetry (SLDF), an established method used to measure retinal microcirculation, has been successfully applied in hypertensive and post-stroke patients. To the best of our knowledge, no previous studies have assessed the impact of type 1 diabetes and its duration on retinal arteriole structure denoted by wall-to-lumen ratio (WLR) and retinal capillary flow (RCF). MethodsRetinal microcirculation was assessed in 158 patients with type 1 diabetes and 38 age-matched healthy controls. The diabetics were divided into 3 groups: group A with diabetes duration <12 months, group B with diabetes duration between 1 and 10 years, and group C >10 years of diabetes. Retinal capillary structure and perfusion were evaluated using a Heidelberg retina flowmeter and automatically analyzed with full-field perfusion imaging. Diabetes control was assessed by HbA1c measurement. ResultsBoth age and BMI were comparable in all the diabetic patients and the controls (mean age 24.8 ± 4.7 years, mean BMI 22.9 ± 4.1). The patients with newly diagnosed diabetes had the highest HbA1c (11.1%) whereas groups B and C were comparable in this respect (7.8% ± 1.9%; 8.0% ± 1.7%, respectively). In the univariate analyses, RCF was significantly higher in group A (297 ± 121 arbitrary units [AU]) vs group B (236 ± 52 AU; p = 0.007) and group C (236 ± 70 AU; p = 0.008) and comparable to that of the controls (p = 0.46). Additionally, the WLR was highest in group C compared to the other diabetic subgroups and controls (p = 0.47). ConclusionsNew-onset diabetes is associated with an increase in RCF, which then gradually decreased with the duration of the disease. Structural changes of the retinal arterioles estimated via WLR are evident later in the course of diabetes, especially when the disease duration exceeded 10 years. These results could not be explained by age or diabetes control. Our findings may have important implications for the understanding of the mechanisms underlying increased cardiovascular risk in type 1 diabetes.